Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2022

May 18, 2022

35119_dirs_2022-05-18_13635b65-2561-4cd8-9fad-21e9885bbc52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-05-18

Reporting Person: Straube Richard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-18 COMMON STOCK P 8000 $0.5000 Acquired 8000 Direct